MA, R., AI, C., JA, D., MPA, H., ME, S., & M, T. (2025). Novel Oxadiazole-Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis. Drug development research, 86(3), e70099. https://doi.org/10.1002/ddr.70099
Chicago Style (17th ed.) CitationMA, Robichaud, Chiasson AI, Doiron JA, Hébert MPA, Surette ME, and Touaibia M. "Novel Oxadiazole-Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis." Drug Development Research 86, no. 3 (2025): e70099. https://doi.org/10.1002/ddr.70099.
MLA (9th ed.) CitationMA, Robichaud, et al. "Novel Oxadiazole-Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis." Drug Development Research, vol. 86, no. 3, 2025, p. e70099, https://doi.org/10.1002/ddr.70099.